Febrile Neutropenia
Mostrando 1-12 de 54 artigos, teses e dissertações.
-
1. Improvement of 1st-hour bundle compliance and sepsis mortality in pediatrics after the implementation of the surviving sepsis campaign guidelines
Abstract Objectives To study the impact of the implementation of the Pediatric Surviving Sepsis Campaign protocol on early recognition of sepsis, 1 -h treatment bundle and mortality. Methods Retrospective, single-center study, before and after the implementation of the sepsis protocol. Outcomes: sepsis recognition, compliance with the 1 -h bundle (fluid re
J. Pediatr. (Rio J.). Publicado em: 2021-08
-
2. Evaluation of risk stratification strategies in pediatric patients with febrile neutropenia
Abstract Objective To evaluate the performance of risk stratification protocols for febrile neutropenia specific to the pediatric population. Methods Retrospective study of a cohort of pediatric patients undergoing cancer treatment with episodes of neutropenia due to chemotherapy and fever, treated at the emergency department of a tertiary cancer hospital
J. Pediatr. (Rio J.). Publicado em: 2021-06
-
3. Bartonella henselae bacteremia diagnosed post-mortem in a myelodysplastic syndrome patient
ABSTRACT This study involves a 49-year-old male, who for three years suffered with a myelodysplastic syndrome and who needed frequent blood transfusions. One day following a transfusion, he presented fever and abdominal pain. The fever became persistent and only improved temporarily with two cycles of intravenous ciprofloxacin. Nearly 120 days after beginnin
Rev. Inst. Med. trop. S. Paulo. Publicado em: 12/09/2019
-
4. The clinical efficacy and safety of paclitaxel combined with avastin for NSCLC patients diagnosed with malignant pleural effusion
Summary Objective: The current study aimed to investigate the clinical efficacy of paclitaxel combined with avastin for non-small cell lung cancer (NSCLC) patients diagnosed with malignant pleural effusion (MPE). Method: Total of 33 patients diagnosed with NSCLC as well as malignant pleural effusion were included. All of them received paclitaxel (175 mg/m2
Rev. Assoc. Med. Bras.. Publicado em: 2018-03
-
5. The safety and clinical efficacy of recombinant human granulocyte colony stimulating factor injection for colon cancer patients undergoing chemotherapy
Summary Objective: The present study was designed to evaluate safety and efficacy of recombinant human granulocyte colony stimulating factor (G-CSF) injection and whether this regimen could reduce the incidence of adverse events caused by chemotherapy. Method: A total of 100 patients with colon cancer who were treated with chemotherapy in our hospital from
Rev. Assoc. Med. Bras.. Publicado em: 2017-12
-
6. The importance of risk factors for the prediction of patients with invasive pulmonary aspergillosis
Summary Objective: Invasive pulmonary aspergillosis (IPA) is a major challenge in the management of immunocompromised patients. Despite all the advances in diagnosis, it remains a problem. The purpose of our study was to investigate the risk factors associated with IPA seen in patients with hematological malignancies. Method: A total of 152 febrile neutrop
Rev. Assoc. Med. Bras.. Publicado em: 2017
-
7. A phase III, randomized, non-inferiority study comparing the efficacy and safety of biosimilar filgrastim versus originator filgrastim for chemotherapy-induced neutropenia in breast cancer patients
OBJECTIVES: To compare the efficacy and safety of two filgrastim formulations for controlling chemotherapy-induced neutropenia and to evaluate the non-inferiority of the test drug relative to the originator. METHODS: This phase III non-inferiority study had a randomized, multicenter, and open-label design. The patients were randomized at a ratio of 1:1 wit
Clinics. Publicado em: 2016-10
-
8. Use of biomarkers in the management of febrile neutropenia episodes in children with cancer
Rev. Bras. Hematol. Hemoter.. Publicado em: 2016-06
-
9. Could CD64 expression be used as a predictor of positive culture results in children with febrile neutropenia?
ABSTRACT Background: Early recognition of infectious processes in neutropenic patients is hampered by the fact that these processes may have dissimilar and non-specific clinical presentations. CD64 is a neutrophil surface marker that is not expressed in non-sensitized neutrophils. When the neutrophil is exposed to tumor necrosis factor-alpha it is activat
Rev. Bras. Hematol. Hemoter.. Publicado em: 2015-12
-
10. Rare severe mycotic infections in children receiving empirical caspofungin treatment for febrile neutropenia
ABSTRACTEmpirical antifungal therapy is most often given to patients with leukemia. However breakthrough fungal infections under antifungal therapy are not uncommon. Four children, with hematologic malignant disease developed mycotic breakthrough infections while on empirical caspofungin treatment for a median of 14 (range 11-19) days. Trichosporon asahii wa
Braz J Infect Dis. Publicado em: 2015-10
-
11. Results of high-risk neutropenia therapy of hematology-oncology patients in a university hospital in Uruguay
Background: Febrile neutropenia is an important cause of mortality and morbidity in hematology-oncology patients undergoing chemotherapy. The management of febrile neutropenia is typically algorithm-driven. The aim of this study was to assess the results of a standardized protocol for the treatment of febrile neutropenia. Methods: A retrospective cohort stu
Rev. Bras. Hematol. Hemoter.. Publicado em: 2015-02
-
12. Analysis of the feasibility of early hospital discharge after autologous hematopoietic stem cell transplantation and the implications to nursing care
INTRODUCTION: Autologous hematopoietic stem cell transplantation is a conduct used to treat some hematologic diseases and to consolidate the treatment of others. In the field of nursing, the few published scientific studies on nursing care and early hospital discharge of transplant patients are deficient. Knowledge about the diseases treated using hematopo
Rev. Bras. Hematol. Hemoter.. Publicado em: 2014-07